Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Hum Vaccin. 2009 Apr 22;5(4):242–247. doi: 10.4161/hv.5.4.7050

Table 1. Demographics of the study groups at the start of surveillance (Total Cohort).

Characteristics RTS,S/AS02
N = 153
Rabies
N = 153
Total
N = 306
Ethnicity Mandinka 147 (96.1%) 144 (94.1%) 291 (95.1%)
Other 6 (3.9%) 9 (5.9%) 15 (4.9%)
Age (years) Mean [SD] 26.4 [8.9] 25.9 [9.0] 26.2 [8.9]
Age category
(years)
17 to 19 55 (35.9%) 58 (37.9%) 113 (36.9%)
20 to 24 24 (15.7%) 31 (20.3%) 55 (18.0%)
25 to 34 39 (25.5%) 29 (19.0%) 68 (22.2%)
35 to 40 20 (13.1%) 19 (12.4%) 39 (12.7%)
41 to 45 15 (9.8%) 16 (10.5%) 31 (10.1%)
HBsAg Status Positive 22 (14.4%) 28 (18.3%) 50 (16.3%)
Negative 131 (85.6%) 125 (81.7%) 256 (83.7%)